経皮吸収型皮膚パッチの市場規模、シェア、動向分析レポート：タイプ別、用途別、流通チャネル別、地域別、セグメント予測、2024年～2030年

経皮吸収型皮膚パッチ市場動向

経皮吸収型皮膚パッチの世界市場は、2023年に78億2,000万米ドルと推定され、2024～2030年にかけてCAGR 5.0％で成長すると予測されています。心血管障害、糖尿病、慢性疼痛などの慢性疾患の有病率の上昇、低侵襲治療に対する消費者の嗜好の高まり、世界人口の高齢化、経皮ドラッグデリバリーシステムの技術進歩などが市場を大きく押し上げています。

経皮吸収型皮膚パッチは、従来の経口薬や注射薬に代わる、非侵襲的で便利な代替手段を記載しています。患者のコンプライアンスを向上させ、経口薬にありがちな胃腸の副作用を最小限に抑えることができます。この使いやすさと長期間にわたる安定した薬剤放出は、経皮吸収型皮膚パッチを慢性疾患の管理に特に魅力的なものにしています。

この市場は、主に世界の慢性疾患の有病率の増加によって、大きな成長を遂げています。2024年2月に発表されたCDCの報告書によると、米国では推定1億2,900万人が、がん、心臓病、肥満、糖尿病、高血圧など、少なくとも1つの主要な慢性疾患に罹患しています。慢性疼痛の管理には、通常、鎮痛薬の定期的な投与が必要であるが、経口剤や注射剤では副作用や頻繁な投与が必要なため、面倒な場合があります。

経皮吸収型皮膚パッチは、長期間にわたって薬剤を制御放出することで解決策を提供し、患者のコンプライアンスを高め、治療成績を向上させる。例えば、重度の慢性疼痛管理に使用されるフェンタニル経皮吸収型皮膚パッチは、薬剤を72時間持続的に投与することで、頻繁な投与の必要性を減らし、安定した疼痛緩和を維持します。

マイクロニードル、イオントフォレーシス、浸透促進剤などのドラッグデリバリーシステムの革新は、経皮投薬の範囲を大幅に広げ、高分子や生物製剤にも対応できるようになりました。マイクロニードルパッチは、皮膚に微細な溝を作り、経皮投与が困難な高分子薬剤の投与を可能にします。注目すべき例として、糖尿病患者へのインスリン投与用のマイクロニードルパッチがあります。これは、毎日の注射に代わる痛みのない治療法であり、血糖コントロールを改善する可能性があります。もう一つの画期的な技術であるイオントフォレーシス（Iontophoresis）は、皮膚からの薬剤浸透を高めるために微小な電荷を用います。例えば、IontoPatchは、腱炎や滑液包炎などの治療に抗炎症剤を投与し、薬剤の吸収と効果を高める。こうした進歩が経皮吸収システムの効率と信頼性を高め、新たな治療の可能性を導入することで、市場の成長を促進し、非侵襲的な手段で治療可能な症状の範囲を拡大しています。

低侵襲治療に対する消費者の嗜好の高まりが市場を大きく牽引しています。患者や医療プロバイダーは、痛みの軽減、感染リスクの低減、経口薬や注射よりも副作用が少ないパッチに好意的です。例えば、Biochemie Novartisのホルモン補充療法用パッチEstraderm Mx Patchは、ホルモンを安定的に放出するため、経口HRTで見られるレベルの変動に関連した副作用を最小限に抑えることができます。さらに、禁煙、疼痛管理、神経疾患用のパッチは、目立たず便利なドラッグデリバリー方法を記載しています。この非侵襲的なアプローチは、患者の快適性とコンプライアンスを向上させ、これらの利点に対する認識が広まるにつれて市場の成長を後押しします。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経皮吸収型皮膚パッチ市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 補助市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 経皮吸収型皮膚パッチ市場：タイプ、推定・動向分析

• セグメントダッシュボード
• 経皮吸収型皮膚パッチ市場：タイプ変動分析、2023年と2030年

第5章 経皮吸収型皮膚パッチ市場：用途、推定・動向分析

• セグメントダッシュボード
• 経皮吸収型皮膚パッチ市場：用途変動分析、2023年と2030年

第6章 経皮吸収型皮膚パッチ市場：流通チャネル、推定・動向分析

• セグメントダッシュボード
• 経皮吸収型皮膚パッチ市場：流通チャネル変動分析、2023年と2030年

第7章 経皮吸収型皮膚パッチ市場：地域別、推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2023年
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Teikoku Pharma USA Inc.
  • Viatris Inc.
  • Johnson &Johnson
  • Luye Pharma Group
  • Purdue Pharma Manufacturing LP
  • Henan Lingrui Pharmaceutical Ltd
  • Samyang Biopharmaceuticals Corp.
  • Hisamitsu Pharmaceutical Co, Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Leading Market Players Anticipated to Witness Highest Growth
• Table 4 Global Transdermal Skin Patches Market, By Region, 2018 - 2030 (USD Billion)
• Table 5 Global Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 6 Global Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 7 Global Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 8 North America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
• Table 9 North America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 10 North America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 11 North America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 12 U.S. Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 13 U.S. Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 14 U.S. Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 15 Canada Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 16 Canada Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 17 Canada Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 18 Mexico Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 19 Mexico Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 20 Mexico Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 21 Europe Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
• Table 22 Europe Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 23 Europe Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 24 Europe Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 25 UK Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 26 UK Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 27 UK Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 28 Germany Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 29 Germany Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 30 Germany Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 31 France Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 32 France Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 33 France Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 34 Italy Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 35 Italy Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 36 Italy Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 37 Spain Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 38 Spain Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 39 Spain Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 40 Denmark Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 41 Denmark Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 42 Denmark Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 43 Sweden Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 44 Sweden Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 45 Sweden Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 46 Norway Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 47 Norway Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 48 Norway Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 49 Asia Pacific Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
• Table 50 Asia Pacific Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 51 Asia Pacific Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 52 Asia Pacific Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 53 Japan Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 54 Japan Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 55 Japan Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 56 China Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 57 China Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 58 China Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 59 India Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 60 India Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 61 India Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 62 South Korea Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 63 South Korea Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 64 South Korea Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 65 Australia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 66 Australia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 67 Australia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 68 Thailand Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 69 Thailand Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 70 Thailand Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 71 Latin America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
• Table 72 Latin America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 73 Latin America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 74 Latin America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 75 Brazil Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 76 Brazil Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 77 Brazil Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 78 Argentina Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 79 Argentina Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 80 Argentina Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 81 Middle East and Africa Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
• Table 82 Middle East and Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 83 Middle East and Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 84 Middle East & Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 85 South Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 86 South Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 87 South Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 88 Saudi Arabia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 89 Saudi Arabia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 90 Saudi Arabia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 91 UAE Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 92 UAE Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 93 UAE Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
• Table 94 Kuwait Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
• Table 95 Kuwait Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
• Table 96 Kuwait Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Transdermal Skin Patches market segment scope and defination
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2023)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Transdermal Skin Patches market: Type movement analysis
• Fig. 17 Transdermal Skin Patches market: Type segment dashboard
• Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
• Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 20 Multi-layer Drug-in-AdhesiveTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 21 MatrixTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 22 Other TypesTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 23 Transdermal Skin Patches market: Application movement analysis
• Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
• Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
• Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
• Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 36 Regional outlook, 2023 & 2030
• Fig. 37 Regional market dashboard
• Fig. 38 Regional market place: Key takeaways
• Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 47 Italy implantable Market, 2018 - 2030 (USD Billion)
• Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
• Fig. 67 Heat map analysis
• Fig. 68 Market differentiators

Transdermal Skin Patches Market Trends

The global transdermal skin patches market was estimated at USD 7.82 billion in 2023 and is projected to grow at a CAGR of 5.0% from 2024 to 2030. The rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, chronic pain, etc., increased consumer preference for minimally invasive treatment, the aging global population, and technological advancements in transdermal drug delivery systems have significantly boosted the market.

Transdermal patches provide a noninvasive, convenient alternative to traditional oral and injectable medications. They enhance patient compliance and minimize the gastrointestinal side effects that often accompany oral drugs. This ease of use and consistent drug release over extended periods make transdermal patches particularly attractive for managing chronic conditions.

The market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases worldwide. According to the CDC report published in February 2024, an estimated 129 million people in the U.S. have at least 1 major chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. Managing chronic pain typically involves regular administration of pain relief medication, which can be cumbersome with oral or injectable forms due to their side effects and the need for frequent dosing.

Transdermal patches offer a solution by providing a controlled release of medication over extended periods, which enhances patient compliance and improves therapeutic outcomes. For instance, the fentanyl transdermal patch, used for managing severe chronic pain, delivers the drug continuously for 72 hours, reducing the need for frequent dosing and maintaining steady pain relief.

Innovations in drug delivery systems, including microneedles, iontophoresis, and permeation enhancers, have significantly broadened the scope of transdermal medication delivery, accommodating large molecules and biologics. Microneedle patches create microscopic channels in the skin, enabling the administration of large molecule drugs that are otherwise difficult to deliver transdermal. A notable example is the microneedle patch for insulin delivery in diabetic patients, which offers a painless alternative to daily injections, potentially improving glycemic control. Iontophoresis, another breakthrough technology, employs a small electric charge to enhance drug penetration through the skin. For instance, IontoPatch delivers anti-inflammatory drugs to treat conditions like tendinitis and bursitis, increasing the drug's absorption and effectiveness. These advancements boost the efficiency and reliability of transdermal delivery systems and introduce new therapeutic possibilities, driving market growth and expanding the range of treatable conditions through non-invasive means.

The rising consumer preference for minimally invasive treatments significantly drives the market. Patients and healthcare providers favor these patches for reduced pain, lower infection risk, and fewer side effects than oral medications or injections. For instance, hormone replacement therapy patches Estraderm Mx Patch by Biochemie Novartis offer a steady hormone release, minimizing side effects linked to fluctuating levels seen with oral HRT. In addition, patches for smoking cessation, pain management, and neurological disorders provide a discreet and convenient drug delivery method. This non-invasive approach enhances patient comfort and compliance, boosting the market growth as awareness of these benefits spreads.

Global Transdermal Skin Patches Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global transdermal skin patches market based on type, application, distribution channel, and region:

• Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Single-layer Drug-in-Adhesive
• Multi-layer Drug-in-Adhesive
• Matrix
• Other Types
• Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Pain Relief
• Smoking Reduction and Cessation Aid
• Cardiovascular Disorders
• Neurological Disorders
• Hormonal Therapy
• Other Applications
• Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application Outlook
  • 2.2.3. Distribution Channel Outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Transdermal Skin Patches Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Industry Analysis - Porter's
    • 3.2.3.1. Bargaining power of the suppliers
    • 3.2.3.2. Bargaining power of the buyers
    • 3.2.3.3. Threats of substitution
    • 3.2.3.4. Threats from new entrants
    • 3.2.3.5. Competitive rivalry
  • 3.2.4. PESTEL Analysis
    • 3.2.4.1. Political landscape
    • 3.2.4.2. Economic and Social landscape
    • 3.2.4.3. Technological landscape

Chapter 4. Transdermal Skin Patches Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Transdermal Skin Patches Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.2.1. Single-layer Drug-in-Adhesive
    • 4.2.1.1. Single-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.2. Multi-layer Drug-in-Adhesive
    • 4.2.2.1. Multi-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.3. Matrix
    • 4.2.3.1. Matrix Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.2.4. Other Types
    • 4.2.4.1. Other Types Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Transdermal Skin Patches Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Transdermal Skin Patches Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.2.1. Pain Relief
    • 5.2.1.1. Pain Relief Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.2. Smoking Reduction
    • 5.2.2.1. Smoking Reduction Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.3. Cardiovascular Disorders
    • 5.2.3.1. Cardiovascular Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.4. Neurological Disorders
    • 5.2.4.1. Neurological Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.5. Hormonal Therapy
    • 5.2.5.1. Hormonal Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.2.6. Other Applications
    • 5.2.6.1. Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Transdermal Skin Patches Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Transdermal Skin Patches Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.2.1. Hospital Pharmacies
    • 6.2.1.1. Hospital Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.2.2. Retail Pharmacies
    • 6.2.2.1. Retail Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.2.3. Online Pharmacies
    • 6.2.3.1. Online Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Transdermal Skin Patches Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company market share analysis, 2023
  • 8.3.2. Teva Pharmaceutical Industries Ltd
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Type benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Novartis AG
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Type benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Teikoku Pharma USA Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Type benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Viatris Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Type benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Johnson & Johnson
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Type benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Luye Pharma Group
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Type benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Purdue Pharma Manufacturing LP
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Type benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Henan Lingrui Pharmaceutical Ltd
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Type benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Samyang Biopharmaceuticals Corp.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Type benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Hisamitsu Pharmaceutical Co, Inc.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Type benchmarking
    • 8.3.11.4. Strategic initiatives